← Open Payments lookup

NICOLE WHITMAN: Open Payments

NPI 1063866937 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$338 in 20 payments from 10 companies in 2025. Trend: 2023 $291 · 2024 $468 · 2025 $338

Food & beverage: $338
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$138
Novo Nordisk Inc2$38
GlaxoSmithKline, LLC.2$33
Sumitomo Pharma America, Inc.2$30
Lilly USA, LLC1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17
Astellas Pharma US Inc1$16
Exact Sciences Corporation1$16
Esperion Therapeutics, Inc.1$16
Amgen Inc.1$15

Products named: AIRSUPRA, FARXIGA, GEMTESA, Ozempic, MOUNJARO, TRELEGY ELLIPTA, Wegovy, CAPLYTA.

Industry payments across MS — which companies pay providers there.